Our Q&As are emailed in our Saturday Morning Report, find the answer to this question below.
Hi MM team, I can't seem to be able to find the stock report for Resmed (RMD). Could you please point me in the right direction? Also, I decided to wait until 29 Jan for Resmed to report, and get some concrete data on their after COVID trajectory, and early impact of Ozempic and alike. Since then, the price moved up quite quickly and I feel I missed an opportunity here. Is it too late to buy? Thanks, Angela
Hi,
RMD has bounced nicely since its January result while also trading ex-dividend 4.8c – not a major yield. While we continue to like RMD chasing the stock around $30, major overhead resistance, isn’t overly exciting – we wouldn’t be surprised to see a short-term pullback towards ~$28 as it feels like the markets a bit long following their solid result.
Take a free trial.
No payment details required.
Forgot password? Request a One Time Password or reset your password
One Time Password
Check your email for an email from [email protected]
Subject: Your OTP for Account Access
This email will have a code you can use as your One Time Password for instant access
A link to create a new password will be sent to the email address you have registered to your account.
Hi, this is only available to members. Join today and access the latest views on the latest developments from a professional money manager.
Our Smart Phone App will give you access to much of our content and notifications. Download for free today.
